Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
<p>Previous therapies and outcome</p>
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Andere auteurs: | , , , , , , , , |
| Gepubliceerd in: |
2025
|
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
| _version_ | 1849927633700126720 |
|---|---|
| author | Caroline Robert (15032672) |
| author2 | Céleste Lebbé (15053390) Thierry Lesimple (15033111) Eija Lundström (15053393) Valérie Nicolas (15053396) Bruno Gavillet (15053399) Philippa Crompton (15053402) Barouyr Baroudjian (15053405) Emilie Routier (15053408) Ferdy J. Lejeune (15053411) |
| author2_role | author author author author author author author author author |
| author_facet | Caroline Robert (15032672) Céleste Lebbé (15053390) Thierry Lesimple (15033111) Eija Lundström (15053393) Valérie Nicolas (15053396) Bruno Gavillet (15053399) Philippa Crompton (15053402) Barouyr Baroudjian (15053405) Emilie Routier (15053408) Ferdy J. Lejeune (15053411) |
| author_role | author |
| dc.creator.none.fl_str_mv | Caroline Robert (15032672) Céleste Lebbé (15053390) Thierry Lesimple (15033111) Eija Lundström (15053393) Valérie Nicolas (15053396) Bruno Gavillet (15053399) Philippa Crompton (15053402) Barouyr Baroudjian (15053405) Emilie Routier (15053408) Ferdy J. Lejeune (15053411) |
| dc.date.none.fl_str_mv | 2025-11-25T13:01:46Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30706809 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_2_from_Phase_I_Study_of_Androgen_Deprivation_Therapy_in_Combination_with_Anti_PD-1_in_Melanoma_Patients_Pretreated_with_Anti_PD-1/30706809 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Immuno-oncology Immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| dc.title.none.fl_str_mv | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Previous therapies and outcome</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_5825016daaa2e2d7e9ef03a592a38e51 |
| identifier_str_mv | 10.1158/1078-0432.30706809 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30706809 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1Caroline Robert (15032672)Céleste Lebbé (15053390)Thierry Lesimple (15033111)Eija Lundström (15053393)Valérie Nicolas (15053396)Bruno Gavillet (15053399)Philippa Crompton (15053402)Barouyr Baroudjian (15053405)Emilie Routier (15053408)Ferdy J. Lejeune (15053411)CancerImmuno-oncologyImmunotherapyCheckpoint blockadeCombination immunotherapySkin CancersMelanoma<p>Previous therapies and outcome</p>2025-11-25T13:01:46ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30706809https://figshare.com/articles/dataset/Supplementary_Table_2_from_Phase_I_Study_of_Androgen_Deprivation_Therapy_in_Combination_with_Anti_PD-1_in_Melanoma_Patients_Pretreated_with_Anti_PD-1/30706809CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307068092025-11-25T13:01:46Z |
| spellingShingle | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 Caroline Robert (15032672) Cancer Immuno-oncology Immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| status_str | publishedVersion |
| title | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| title_full | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| title_fullStr | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| title_full_unstemmed | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| title_short | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| title_sort | Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 |
| topic | Cancer Immuno-oncology Immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |